ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2018

Phase I-II clinical trial design: a state-of-the-art paradigm for dose finding.

F Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.